Overview

Study of Difluprednate Ophthalmic Emulsion in Postoperative Inflammation

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this phase 3 study is to determine if difluprednate ophthalmic emulsion is effective in the treatment of postoperative inflammation.
Phase:
Phase 3
Details
Lead Sponsor:
Sirion Therapeutics, Inc.
Treatments:
Difluprednate
Fluprednisolone